HT
CRSP icon

HAP Trading’s CRISPR Therapeutics CRSP Stock Holding History

HAP Trading’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,400
Closed -$98.9K – 782
2023
Q4 		$98.9K Hold
50,400
– – 0.02% 371
2023
Q3 		$800K Sell
50,400
-200
-0.4% -$10.3K 0.13% 155
2023
Q2 		$547K Buy
+50,600
New +$2.87M 0.1% 184
2022
Q4 		– Sell
-10,900
Closed -$244K – 1587
2022
Q3 		$244K Sell
10,900
-5,700
-34% -$413K 0.02% 542
2022
Q2 		$388K Sell
16,600
-7,800
-32% -$459K 0.02% 507
2022
Q1 		$741K Sell
24,400
-5,400
-18% -$339K 0.03% 424
2021
Q4 		$927K Buy
29,800
+4,800
+19% +$419K 0.03% 499
2021
Q3 		$481K Sell
25,000
-6,500
-21% -$816K 0.02% 695
2021
Q2 		$285K Buy
31,500
+2,100
+7% +$255K 0.01% 857
2021
Q1 		$737K Buy
29,400
+3,100
+12% +$468K 0.04% 382
2020
Q4 		$314K Buy
+26,300
New +$3.11M 0.01% 789
2020
Q3 		– Sell
-22,300
Closed -$21K – 1627
2020
Q2 		$21K Buy
22,300
+8,400
+60% +$491K ﹤0.01% 1295
2020
Q1 		$121K Sell
13,900
-8,800
-39% -$454K 0.01% 637
2019
Q4 		$64K Buy
22,700
+6,100
+37% +$333K ﹤0.01% 664
2019
Q3 		$72K Buy
16,600
+6,400
+63% +$306K 0.01% 678
2019
Q2 		$22K Sell
10,200
-6,500
-39% -$260K ﹤0.01% 863
2019
Q1 		$54K Buy
+16,700
New +$577K ﹤0.01% 658
2018
Q4 		– Sell
-14,000
Closed -$105K – 1146
2018
Q3 		$105K Buy
14,000
+1,200
+9% +$62.8K 0.01% 538
2018
Q2 		$36K Buy
+12,800
New +$729K ﹤0.01% 732

Other funds holding CRSP

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

HAP Trading's CRSP Position: Q2 2022 in Review

HAP Trading sold out of CRISPR Therapeutics (CRSP) in Q2 2022, closing a stake of 10,951 shares — an estimated $644K sold.

HAP Trading first reported a position in CRSP in Q2 2020 and held it in 5 quarters. The position peaked at $1.62M in Q4 2020. 435 funds tracked by Wall St. Rank hold CRSP as of Q2 2022.

  • HAP Trading reported no remaining CRISPR Therapeutics position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 10,951 CRISPR Therapeutics shares in Q2 2022, an estimated $644K.
  • HAP Trading first reported a position in CRISPR Therapeutics in Q2 2020 and held it in 5 quarters.
  • HAP Trading's CRISPR Therapeutics position peaked at $1.62M in Q4 2020.
  • 435 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.